Ginkgo

The dosage of Ginkgo can vary significantly depending on the condition being addressed and the specific formulation used. Most clinical trials have utilized a standardized extract known as EGb 761.

• Cognitive Support and Dementia: The standard adult dosage typically ranges from 120 mg to 240 mg per day, usually divided into two or three doses (e.g., 60 mg three times daily or 120 mg twice daily).
• Peripheral Vascular Disease (Intermittent Claudication): Doses of 120 mg to 160 mg per day are common, often split into two doses.
• Vertigo and Tinnitus: Clinical studies often employ 120 mg to 160 mg per day.
• General Antioxidant Support: Lower doses of 40 mg to 80 mg per day are sometimes used for general wellness, though clinical evidence for this use is limited.

It is recommended to start at a lower dose (e.g., 40 mg to 60 mg) and gradually increase to the target dose over several weeks to minimize the risk of gastrointestinal side effects.

Ginkgo is not recommended for use in children (individuals under 18 years of age). There is insufficient safety data regarding the effects of Ginkgo on developing neurological and endocrine systems. Furthermore, the risk of accidental poisoning from ginkgo-containing products (especially seeds) is significantly higher in the pediatric population.

Renal Impairment

There are no specific established guidelines for Ginkgo dosage in patients with kidney disease. However, since ginkgolides are partially excreted through the kidneys, patients with significant renal impairment should use Ginkgo with caution and under close medical supervision.

Hepatic Impairment

Ginkgo is metabolized by the liver. Patients with liver cirrhosis or hepatitis may experience altered metabolism of the extract. While specific dose reductions are not standardized, healthcare providers may suggest lower doses or more frequent monitoring for these patients.

Elderly Patients

No specific dose adjustment is generally required for the elderly; however, this population is at higher risk for spontaneous bleeding and drug interactions. Healthcare providers should carefully review the patient's entire medication list, particularly anticoagulants (blood thinners).

• Consistency: Take Ginkgo at the same time(s) each day to maintain steady levels in the bloodstream.
• With or Without Food: Ginkgo can be taken with or without food. Taking it with a meal may help reduce the likelihood of stomach upset.
• Swallow Whole: Tablets and capsules should be swallowed whole with a full glass of water. Do not crush or chew standardized tablets unless specifically instructed, as this may interfere with the controlled release of the extract.
• Storage: Store Ginkgo products in a cool, dry place away from direct sunlight and moisture. Keep the container tightly closed and out of reach of children.

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of side effects.

Signs of a Ginkgo overdose may include severe gastrointestinal distress, extreme dizziness, headache, or unusual bleeding. In severe cases, particularly if ginkgo seeds were consumed, seizures or loss of consciousness may occur due to ginkgotoxin.

In the event of a suspected overdose:

1. 1Contact your local Poison Control Center immediately.
2. 2Seek emergency medical attention if the person is having a seizure or difficulty breathing.
3. 3Do not induce vomiting unless directed by medical personnel.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop taking Ginkgo without medical guidance, especially if you are using it for a chronic circulatory or cognitive condition.

While Ginkgo is generally well-tolerated when taken at recommended doses, some patients may experience mild adverse effects. The most common side effects include:

• Gastrointestinal Upset: This may manifest as nausea, diarrhea, stomach pain, or indigestion. These symptoms are usually mild and often resolve as the body adjusts to the supplement.
• Headache: Some users report mild to moderate headaches shortly after starting Ginkgo. Increasing water intake or slightly reducing the dose may alleviate this.
• Dizziness: A feeling of lightheadedness or vertigo can occur, particularly when standing up quickly.

• Palpitations: A sensation of a racing or fluttering heart. Patients with pre-existing heart conditions should monitor this closely.
• Constipation: Some individuals may experience a slowing of bowel movements.
• Dermatological Reactions: Mild skin rashes, itching, or hives (urticaria) have been reported in some users.

• Severe Allergic Reactions: Though rare, some individuals may experience anaphylaxis (a life-threatening allergic reaction).
• Seizures: This is most commonly associated with the consumption of ginkgo seeds or very high doses of leaf extract in susceptible individuals.
• Spontaneous Bleeding: Rare cases of bleeding into the eye (hyphema) or the brain (subdural hematoma) have been documented.

> Warning: Stop taking Ginkgo and call your doctor immediately if you experience any of these serious symptoms:

• Unusual Bleeding or Bruising: This includes frequent nosebleeds, bleeding gums, or blood in the urine or stool. This may indicate that Ginkgo is interfering with your blood's ability to clot.
• Signs of a Stroke: Sudden weakness (especially on one side of the body), severe headache, slurred speech, or vision changes. While Ginkgo is used for circulation, it has been rarely linked to bleeding in the brain.
• Seizures or Convulsions: Ginkgo can lower the seizure threshold, especially in patients with a history of epilepsy.
• Severe Allergic Reaction (Anaphylaxis): Swelling of the face, lips, or throat; difficulty breathing; or a widespread, blistering skin rash.
• Fainting or Severe Dizziness: This may indicate a significant drop in blood pressure or an irregular heart rhythm.

Long-term use of Ginkgo has been studied in clinical trials lasting several years. While generally safe, some concerns have been raised regarding:

• Thyroid Changes: Some animal studies suggested an increased risk of thyroid tumors with very high, long-term doses, though this has not been clearly replicated in humans.
• Liver Enzyme Elevation: Prolonged use of high doses may occasionally lead to minor elevations in liver function tests, requiring monitoring by a healthcare provider.
• Chronic Bleeding Risk: The cumulative effect on platelet aggregation may increase the risk of minor bleeding events over time, especially in the elderly.

No FDA black box warnings for Ginkgo. Because Ginkgo is primarily regulated as a dietary supplement in the U.S., it does not carry the same mandatory black box labeling as prescription pharmaceuticals. However, this does not mean the substance is without risk. The absence of a black box warning should not be interpreted as a guarantee of safety, particularly for patients on anticoagulants or those with seizure disorders.

Report any unusual symptoms or persistent side effects to your healthcare provider. Keeping a symptom diary can help your doctor determine if the side effects are related to Ginkgo or another underlying condition.

Ginkgo is a potent biological agent that can significantly affect blood clotting and neurological function. It is not a "simple herb" and must be treated with the same caution as a prescription medication. Patients should never exceed the recommended dose and must ensure they are using a high-quality, standardized extract to avoid contamination with ginkgolic acids, which can be toxic.

No FDA black box warnings for Ginkgo. However, clinical guidelines from various medical organizations emphasize the risk of bleeding when combined with other anticoagulants.

• Bleeding Disorders: Ginkgo may increase the risk of bleeding. If you have a bleeding disorder (such as hemophilia) or are taking medications that thin the blood, you must consult a hematologist before using Ginkgo.
• Surgery: Because of its anti-platelet effects, Ginkgo must be discontinued at least two weeks prior to any scheduled surgery or dental procedure to prevent excessive bleeding during or after the operation.
• Seizure History: Ginkgo seeds contain ginkgotoxin, and even leaf extracts may contain trace amounts. Ginkgo has been reported to lower the seizure threshold. Patients with epilepsy or a history of seizures should avoid Ginkgo.
• Diabetes: Ginkgo may affect how the body handles insulin and blood sugar. Patients with diabetes should monitor their blood glucose levels closely when starting or stopping Ginkgo, as adjustments to diabetes medications may be necessary.
• Allergic Sensitivity: Individuals allergic to poison ivy, poison oak, poison sumac, cashews, or mango shells may experience cross-reactivity with Ginkgo (specifically the fruit and seeds) due to the presence of alkylphenols.

If you are taking Ginkgo long-term, your healthcare provider may recommend the following:

• Coagulation Panels: Tests such as Prothrombin Time (PT) and International Normalized Ratio (INR), especially if you are also taking warfarin.
• Liver Function Tests (LFTs): Periodic monitoring of enzymes (ALT, AST) to ensure hepatic health.
• Blood Glucose Monitoring: For diabetic patients, more frequent self-monitoring of blood sugar.
• Neurological Assessment: Regular check-ups to evaluate the effectiveness of Ginkgo if used for cognitive decline.

Ginkgo may cause dizziness or headaches in some individuals. If you experience these side effects, you should avoid driving or operating heavy machinery until you know how the supplement affects you.

Combining Ginkgo with alcohol is generally not recommended. Alcohol can also thin the blood and increase the risk of gastrointestinal irritation. Using both together may exacerbate the risk of bleeding and increase the sedative effects or dizziness associated with Ginkgo.

Ginkgo does not typically require a tapering period; however, if you have been taking it for a circulatory condition, stopping it suddenly may result in a return of symptoms (e.g., decreased walking distance in claudication). Always inform your surgeon or primary doctor if you stop taking Ginkgo.

> Important: Discuss all your medical conditions, including any history of bleeding, seizures, or planned surgeries, with your healthcare provider before starting Ginkgo.

• Efavirenz (Sustiva): Ginkgo may significantly decrease the blood levels of this HIV medication, potentially leading to treatment failure and drug resistance. This is thought to occur through the induction of CYP3A4 enzymes.
• Talcazuzumab/Immunotherapies: Due to its classification as a Non-Standardized Plant Allergenic Extract, Ginkgo may interfere with certain specific immunotherapy protocols. Consult an allergist.

• Warfarin (Coumadin): Ginkgo can enhance the anticoagulant effect of warfarin, significantly increasing the risk of life-threatening bleeding. If used together, INR must be monitored extremely closely.
• Antiplatelet Drugs (Clopidogrel, Aspirin): Combining Ginkgo with these drugs creates a synergistic effect on platelets, making it much harder for the blood to clot.
• Anticonvulsants (Valproic Acid, Phenytoin): Ginkgo may decrease the effectiveness of these medications, increasing the risk of breakthrough seizures.
• NSAIDs (Ibuprofen, Naproxen): Regular use of NSAIDs with Ginkgo increases the risk of gastrointestinal bleeding.

• Selective Serotonin Reuptake Inhibitors (SSRIs - e.g., Fluoxetine, Sertraline): There have been rare reports of serotonin syndrome and increased bleeding risk when Ginkgo is combined with SSRIs.
• Alprazolam (Xanax): Ginkgo may decrease the effectiveness of alprazolam by increasing its metabolism.
• Diabetes Medications: Ginkgo may alter the response to insulin or oral hypoglycemic agents (like metformin), requiring dosage adjustments.
• Nifedipine: Ginkgo may increase the levels of this blood pressure medication in the body, leading to low blood pressure and increased side effects.

• High-Fat Meals: Taking Ginkgo with a very high-fat meal may slightly delay the time it takes to reach peak blood concentrations, though it does not reduce overall absorption.
• Caffeine: Ginkgo may enhance the stimulant effects of caffeine, leading to jitteriness or increased heart rate.
• Alcohol: Increases the risk of bleeding and dizziness.

• St. John's Wort: May further induce CYP450 enzymes, complicating the metabolism of other drugs.
• Garlic, Ginger, Ginseng, and Saw Palmetto: These supplements also have blood-thinning properties. Combining them with Ginkgo significantly compounds the risk of spontaneous bleeding.
• Vitamin E: High doses of Vitamin E (over 400 IU) have antiplatelet effects that may interact with Ginkgo.

• Coagulation Tests: Ginkgo can affect PT/INR and bleeding time results.
• Blood Glucose Tests: May cause fluctuations in readings for diabetic patients.
• Liver Function Tests: Rare elevations in transaminases may be observed.

For each major interaction, the mechanism typically involves either pharmacodynamic synergy (both substances doing the same thing, like thinning blood) or pharmacokinetic interference (Ginkgo changing how the liver processes the other drug). The clinical consequence is usually either increased toxicity of the other drug or a reduction in its efficacy.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is the best way to prevent dangerous interactions.

• Hypersensitivity: Ginkgo must NEVER be used by individuals with a known allergy to Ginkgo biloba or any components of the formulation. This includes severe reactions to other members of the Anacardiaceae family (e.g., poison ivy, cashews).
• Active Pathological Bleeding: Patients with an active peptic ulcer, intracranial hemorrhage, or any other significant bleeding disorder must not use Ginkgo, as its PAF-antagonist properties will exacerbate blood loss.
• Upcoming Major Surgery: Ginkgo is contraindicated in the immediate preoperative period (at least 14 days prior to surgery) due to the risk of perioperative hemorrhage.
• Pregnancy (Late Term): Use is contraindicated near term due to the risk of maternal and fetal bleeding.

• Epilepsy: Because Ginkgo may lower the seizure threshold, it should only be used under extreme caution and specialist supervision in patients with a history of seizures.
• Fertility Issues: Some laboratory data suggest that high doses of Ginkgo may interfere with oocyte (egg) fertilization, so those attempting to conceive should discuss use with a fertility specialist.
• Severe Renal or Hepatic Disease: Requires careful risk-benefit analysis due to altered drug clearance.

Patients who are sensitive to urushiols (the oils found in poison ivy, poison oak, and poison sumac) are at a high risk of cross-sensitivity with Ginkgo fruit and seeds. While standardized leaf extracts are processed to remove most of these allergens, highly sensitive individuals should exercise extreme caution.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of bleeding or allergies, before determining if Ginkgo is safe for you.

Pregnancy Category: Not Formally Rated (Avoid Use).

There is insufficient evidence to guarantee the safety of Ginkgo during pregnancy. The primary concern is the antiplatelet effect, which could lead to increased bleeding for both the mother and the fetus. Some animal studies have suggested potential teratogenic effects (birth defects) at extremely high doses, though human data is lacking. Furthermore, Ginkgo may act as a uterine stimulant in some contexts. Therefore, healthcare providers generally advise against the use of Ginkgo during all trimesters of pregnancy.

It is not known whether the constituents of Ginkgo pass into human breast milk. Because of the potential for Ginkgo to affect platelet function in the nursing infant and the lack of safety data, breastfeeding while taking Ginkgo is not recommended. Mothers should discuss alternative options for cognitive or circulatory support with their doctor.

Ginkgo is not approved for use in children. Clinical trials have not established a safe or effective dose for the pediatric population. There is a specific risk of ginkgotoxin-induced seizures in children who might accidentally ingest ginkgo-containing products.

The elderly are the most frequent users of Ginkgo, often for age-related memory loss. While it may offer benefits, this population is also at the highest risk for:

• Fall-Related Bleeding: If an elderly patient on Ginkgo falls, they are at a higher risk for internal bleeding or hematomas.
• Polypharmacy: The elderly often take multiple medications (blood pressure, heart, diabetes), increasing the likelihood of drug interactions.
• Renal Decline: Natural age-related decrease in kidney function may lead to higher systemic levels of Ginkgo components.

Patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should use Ginkgo with caution. There is no specific data on dialysis clearance of Ginkgo, but it is generally advised to avoid starting new supplements during acute renal failure.

In patients with Child-Pugh Class B or C hepatic impairment, the metabolism of Ginkgo may be significantly slowed. This can lead to an accumulation of active metabolites and an increased risk of side effects, particularly bleeding. Healthcare providers may recommend avoiding use in cases of severe liver failure.

> Important: Special populations require individualized medical assessment. Never start Ginkgo if you are pregnant, nursing, or treating a child without direct medical supervision.

Ginkgo biloba extract (specifically the standardized EGb 761) operates through a multi-target mechanism. The terpene lactones (ginkgolides A, B, and C) are highly specific, competitive antagonists of the Platelet-Activating Factor (PAF) receptor. By blocking this receptor, Ginkgo inhibits platelet aggregation, reduces vascular permeability, and prevents the inflammatory cascade triggered by PAF.

The flavonoid glycosides act as potent antioxidants. They scavenge free radicals such as superoxide and hydroxyl radicals, protecting the lipid membranes of neurons and vascular cells from lipid peroxidation. In the brain, Ginkgo has been shown to increase the density of muscarinic acetylcholine receptors and alpha-2 adrenergic receptors, which may explain its effects on focus and memory.

• Vascular Effects: Ginkgo induces vasodilation by stimulating the release of nitric oxide (NO) and prostacyclin. This reduces peripheral vascular resistance and improves blood flow without significantly altering systemic blood pressure.
• Neuroprotective Effects: By maintaining mitochondrial respiratory chain function, Ginkgo helps neurons survive periods of low oxygen (ischemia).
• Onset of Action: For cognitive effects, it may take 4 to 6 weeks of consistent use to notice benefits. For peripheral circulatory issues, 6 to 12 weeks may be required.

| Parameter | Value |

|---|---|

| Bioavailability | 70% - 100% (Ginkgolides) |

| Protein Binding | < 15% |

| Half-life | 3 - 6 hours |

| Tmax | 1 - 2 hours |

| Metabolism | Hepatic (CYP2C19, CYP3A4 involvement) |

| Excretion | Renal (approx. 70%), Fecal (approx. 30%) |

• Molecular Components: Contains 24% Ginkgo-flavone glycosides and 6% Terpene lactones.
• Key Molecules: Ginkgolide B (C20H24O10), Bilobalide (C15H18O8).
• Solubility: Active extracts are generally soluble in ethanol and partially soluble in water.

Ginkgo is categorized as a Non-Standardized Plant Allergenic Extract [EPC]. Within the therapeutic realm, it is often grouped with "Nootropics" (cognitive enhancers) and "Peripheral Vasodilators."